NCT04787237

Brief Summary

immediate implant placement using the VST was compared to early implant placement protocol using Buser's technique regarding implant survival, changes in labial plate thickness and soft tissue height after 1 year of implant placement

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 30, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 8, 2021

Completed
Last Updated

April 26, 2022

Status Verified

April 1, 2022

Enrollment Period

1.6 years

First QC Date

March 4, 2021

Last Update Submit

April 25, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • vertical and horizontal soft tissue changes

    Amount of soft tissue changes were identified midfacially and at the apex of the mesial and distal papillae by superimposing the STL files of the models, obtained via intra-oral scanning, at the baseline (of the unrestorable tooth) with those after 12 months of implant insertion. The 3D software roughly aligned of both pre-and postoperative models through 3 identical points, identified on their surfaces. The best-fit algorithm of the software then perfected the superimposition process. The superimposed models were then imported into an STL viewer, where the measurements were performed. This method was proven to be accurate in volumetric measurements of hard and soft tissues.

    crown delivery and 1 year

Secondary Outcomes (2)

  • labial plate thickness changes

    implant insertion -1 year

  • implant survival

    Implant insertion- 1 year

Study Arms (2)

Vestibulart socket therapy and immediate implants

EXPERIMENTAL

A subperiosteal tunnel was created connecting the socket orifice and the vestibular access incision using periotomes and micro periosteal elevators (. Implant fixture were then inserted . A flexible cortical membrane shield that is made of cortical bone of heterologous origin was introduced from the vestibular access incision reaching 1 mm below the socket orifice through the tunnel then stabilized using a membrane tack or a micro screw to the alveolar bone apical to the base of the socket . The socket gap between the implant and the shield was then packed thoroughly with particulate bone graft

Other: VST and immediate implants

Buser's technique and early implant placement

ACTIVE COMPARATOR

In Buser's group early implant placement, the failing tooth was extracted atraumatically using a periotome. A collagen plug was placed to stabilize the wound clot. A healing period of 4-8 weeks was followed. Then an open flap implant surgery using a triangular flap design was cut. Implant was then placed under the crest of the palatal bone. A healing abutment was then attached. Contour augmentation was done using autogenous bone chips mixed with saline and bone conditioned medium (BCM) added to bioss bone granules to activate it.

Other: Buser technique and early implants placement

Interventions

One-cm long vestibular access incision was made using a 15c blade 3-4 mm apical to the mucogingival junction at the related socket . A subperiosteal tunnel was created connecting the socket orifice and the vestibular access incision using periotomes and micro periosteal elevators (. Implant fixture were then inserted after drilling to its pre-planned location 3-4 mm apical to socket base with adequate primary stability achieved using a torque wrench reaching 30 Ncm torque . A flexible cortical membrane shield that is made of cortical bone of heterologous origin of 0.6 mm thickness was hydrated and then trimmed and introduced from the vestibular access incision reaching 1 mm below the socket orifice through the tunnel . The socket gap between the implant and the shield was then packed thoroughly with particulate bone graft

Also known as: VST
Vestibulart socket therapy and immediate implants

In Buser's group early implant placement, the failing tooth was extracted atraumatically using a periotome. A collagen plug was placed to stabilize the wound clot. A healing period of 4-8 weeks (depending on the size of the extracted tooth) was followed. Then an open flap implant surgery using a triangular flap design was cut. After preparing the implant bed, the site was irrigated using normal saline. A healing abutment was then attached. Contour augmentation was done using autogenous bone chips mixed with saline and bone. A non-cross liked membrane was then placed, after being soaked with BCM. Finally, the healing abutment was removed and the flap was released to allow for its suturing.

Also known as: contour augmentation and early implant placement
Buser's technique and early implant placement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • all patients were adults ≥ 18 years
  • non-adjacent hopeless maxillary teeth in the esthetic zone.
  • The involved teeth had type II sockets.
  • To achieve optimum primary stability for the implants (30Ncm insertion torque), adequate palatal and at least 3 mm apical bone should be available to engage the immediately placed implants.

You may not qualify if:

  • Smoking and/or pregnant patients
  • systemic diseases
  • a history of chemo- or radiotherapy within the past 2 years were excluded.
  • Infected sockets were also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Faculty of dentistry

Cairo, Manial, 12911, Egypt

Location

ElAskary and Associates Private clinic

Alexandria, Egypt

Location

Study Officials

  • Iman Radi, PhD

    Cairo University

    STUDY DIRECTOR
  • AbdelSalam Alaskary, BDS

    Private Practice

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
AE and IR were responsible for measuring the outcomes and they were blinded to the treatments, since they were not involved in the treatment The statistician was also blinded to the treatment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized clinical trial, blinded
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 4, 2021

First Posted

March 8, 2021

Study Start

January 30, 2019

Primary Completion

August 31, 2020

Study Completion

October 31, 2020

Last Updated

April 26, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations